Co-Diagnostics Inc (CODX) Stock Price, Quote & News

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus...

Industry: Medical Devices

Sector: Healthcare

Phone: 801 438 1036

Website: co-dx.com

Address:

2401 S. Foothill Dr., Suite D, Salt Lake City, United States

Antiquarian Apr. 25 at 1:48 PM

$CODX

1 · Reply

Antiquarian Apr. 25 at 6:59 AM

$CODX

0 · Reply

Minutiae Apr. 25 at 4:59 AM

$CODX CDC Respiratory Virus Activity Levels Apr. 24, 2026 For Everyone Provides an update on how COVID-19, influenza, and RSV may be spreading nationally and in your state. https://www.cdc.gov/respiratory-viruses/data/activity-levels.html

0 · Reply

Minutiae Apr. 25 at 4:59 AM

$CODX Apr 24 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx

0 · Reply

Minutiae Apr. 25 at 4:57 AM

$CODX Apr 24 CODX volume 82,270 closing at $1.67. 7,990 after-hour shares trading at $1.64 to $1.7399. FINRA Short Sale Volume 15,168 shorted shares out of 39,374. CODX short volume 39%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting

0 · Reply

coolmate25 Apr. 24 at 8:19 PM

$CODX Busy ars tugs were dealing today .

0 · Reply

Antiquarian Apr. 24 at 1:22 PM

$CODX 1.80s today maybe?

1 · Reply

Antiquarian Apr. 24 at 1:21 PM

$CODX

0 · Reply

Minutiae Apr. 24 at 5:49 AM

$CODX Apr 23 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx

0 · Reply

Minutiae Apr. 24 at 5:47 AM

$CODX Apr 23 CODX volume 198,262 closing at $1.71. 9,160 after-hour shares trading at $1.6858 to $1.75. FINRA Short Sale Volume 39,139 shorted shares out of 98,475. CODX short volume 40%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting

0 · Reply

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

Apr 14, 2026, 9:00 AM EDT - 11 days ago

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

Apr 9, 2026, 9:00 AM EDT - 16 days ago

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

Mar 31, 2026, 4:30 PM EDT - 25 days ago

Co-Diagnostics Earnings Call Transcript: Q4 2025

Mar 31, 2026, 4:01 PM EDT - 25 days ago

Co-Diagnostics Reports Full Year 2025 Financial Results

Mar 25, 2026, 8:00 AM EDT - 4 weeks ago

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

Mar 25, 2026, 7:46 AM EDT - 4 weeks ago

EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch

Mar 20, 2026, 8:00 AM EDT - 5 weeks ago

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Mar 20, 2026, 7:56 AM EDT - 5 weeks ago

EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity

Mar 17, 2026, 9:00 AM EDT - 5 weeks ago

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Mar 16, 2026, 9:00 AM EDT - 5 weeks ago

Co-Diagnostics to Present at Medical Korea 2026

Mar 12, 2026, 9:00 AM EDT - 6 weeks ago

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Mar 10, 2026, 9:00 AM EDT - 6 weeks ago

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Feb 9, 2026, 9:00 AM EST - 2 months ago

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Feb 5, 2026, 9:00 AM EST - 2 months ago

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Feb 4, 2026, 9:00 AM EST - 2 months ago

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Jan 12, 2026, 9:00 AM EST - 3 months ago

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Dec 30, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Announces Reverse Stock Split

Dec 29, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Dec 18, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Dec 17, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Dec 9, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Dec 8, 2025, 12:36 PM EST - 4 months ago

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Nov 20, 2025, 9:00 AM EST - 5 months ago

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Nov 18, 2025, 9:00 AM EST - 5 months ago

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Nov 13, 2025, 4:30 PM EST - 5 months ago

Co-Diagnostics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:01 PM EST - 5 months ago

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Nov 5, 2025, 11:00 AM EST - 6 months ago

Co-Diagnostics Transcript: Fireside Chat

Nov 5, 2025, 9:00 AM EST - 6 months ago

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

Nov 3, 2025, 9:00 AM EST - 6 months ago

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Oct 31, 2025, 9:00 AM EDT - 6 months ago

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Oct 30, 2025, 1:57 PM EDT - 6 months ago

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Oct 29, 2025, 12:51 PM EDT - 6 months ago

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 28, 2025, 9:33 AM EDT - 6 months ago

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 22, 2025, 8:30 AM EDT - 6 months ago

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Oct 16, 2025, 9:30 AM EDT - 6 months ago

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Oct 13, 2025, 9:30 AM EDT - 6 months ago

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Sep 30, 2025, 4:15 PM EDT - 7 months ago

Co-Diagnostics Transcript: Lytham Partners Fall 2025 Investor Conference

Sep 30, 2025, 9:30 AM EDT - 7 months ago

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

Sep 18, 2025, 5:05 PM EDT - 7 months ago

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 17, 2025, 9:47 AM EDT - 7 months ago

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 11, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

Sep 9, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Aug 18, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

Aug 14, 2025, 4:30 PM EDT - 9 months ago

Co-Diagnostics Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:01 PM EDT - 9 months ago

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 9:30 AM EDT - 9 months ago

Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast

Jul 15, 2025, 9:30 AM EDT - 10 months ago

Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025

May 14, 2025, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

May 8, 2025, 4:30 PM EDT - 1 year ago

Co-Diagnostics Earnings Call Transcript: Q1 2025

May 8, 2025, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

Apr 29, 2025, 7:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Co-Diagnostics Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

Mar 13, 2025, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

Mar 3, 2025, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

Feb 24, 2025, 8:18 AM EST - 1 year ago

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Nov 7, 2024, 4:30 PM EST - 1 year ago

Co-Diagnostics Earnings Call Transcript: Q3 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Co-Diagnostics Earnings Call Transcript: Q2 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Co-Diagnostics Earnings Call Transcript: Q1 2024

Mar 14, 2024, 4:30 PM EDT - 2 years ago

Co-Diagnostics Earnings Call Transcript: Q4 2023

Nov 9, 2023, 4:30 PM EST - 2 years ago

Co-Diagnostics Earnings Call Transcript: Q3 2023

Aug 10, 2023, 4:30 PM EDT - 2 years ago

Co-Diagnostics Earnings Call Transcript: Q2 2023

May 11, 2023, 4:30 PM EDT - 3 years ago

Co-Diagnostics Earnings Call Transcript: Q1 2023

Mar 16, 2023, 4:30 PM EDT - 3 years ago

Co-Diagnostics Earnings Call Transcript: Q4 2022

Nov 10, 2022, 1:00 PM EST - 3 years ago

Co-Diagnostics Earnings Call Transcript: Q3 2022

Antiquarian Apr. 25 at 1:48 PM

$CODX

1 · Reply

Antiquarian Apr. 25 at 6:59 AM

$CODX

0 · Reply

Minutiae Apr. 25 at 4:59 AM

0 · Reply

Minutiae Apr. 25 at 4:59 AM

$CODX Apr 24 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx

0 · Reply

Minutiae Apr. 25 at 4:57 AM

0 · Reply

coolmate25 Apr. 24 at 8:19 PM

$CODX Busy ars tugs were dealing today .

0 · Reply

Antiquarian Apr. 24 at 1:22 PM

$CODX 1.80s today maybe?

1 · Reply

Antiquarian Apr. 24 at 1:21 PM

$CODX

0 · Reply

Minutiae Apr. 24 at 5:49 AM

$CODX Apr 23 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx

0 · Reply

Minutiae Apr. 24 at 5:47 AM

0 · Reply

Antiquarian Apr. 23 at 8:59 PM

$CODX would be nice to hold this in the 1.70s instead of falling back down. Let’s see what happens.

4 · Reply

Antiquarian Apr. 23 at 8:17 PM

$CODX hey comira wake up

0 · Reply

coolmate25 Apr. 23 at 5:14 PM

$CODX It should hit $3 if get hold by day traders for a couple of days and let short pay for it but parasites are everywhere.

1 · Reply

Pyranha Apr. 23 at 1:10 PM

$CODX I guess a slow week is better than a low week (knock wood) ….

2 · Reply

Antiquarian Apr. 23 at 12:03 PM

$CODX

0 · Reply

Minutiae Apr. 23 at 6:04 AM

$CODX Apr 22 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx

0 · Reply

Minutiae Apr. 23 at 5:42 AM

$CODX Apr 22 CODX volume 98,581 closing at $1.69. 694 after-hour shares trading at $1.66 to $1.7. FINRA Short Sale Volume 22,808 shorted shares out of 61,908. CODX short volume 37%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting

0 · Reply

LondonVentures Apr. 23 at 1:10 AM

$CODX way to go Dwight and team, glad you are on the cutting edge of…uuhhh….well not sure https://people.com/more-than-600-sickened-utah-measles-11955900

0 · Reply

Antiquarian Apr. 22 at 11:11 AM

$CODX

0 · Reply

Minutiae Apr. 22 at 5:31 AM

$CODX Apr 22 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx

1 · Reply

Minutiae Apr. 22 at 5:29 AM

$CODX Apr 22 CODX volume 240,857 closing at $1.64. 784 after-hour shares trading at $1.6 to $1.71. FINRA Short Sale Volume 71,802 shorted shares out of 135,377. CODX short volume 53%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting

1 · Reply

Antiquarian Apr. 21 at 10:17 PM

$CODX

0 · Reply

Market Cap	6.16M
Revenue (ttm)	620,000.00
Net Income (ttm)	-46.90M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-7,564.52%
Debt to Equity Ratio	0.00

Volume	82,200
Avg Vol	1,464,924
Day's Range	N/A - N/A
Shares Out	3.60M
Stochastic %K	74%
Beta	1.42
Analysts	Hold
Price Target	$45.00